Hansen M - Search Results

1

Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.

Bahne E, Sun EWL, Young RL, Hansen M, Sonne DP, Hansen JS, Rohde U, Liou AP, Jackson ML, de Fontgalland D, Rabbitt P, Hollington P, Sposato L, Due S, Wattchow DA, Rehfeld JF, Holst JJ, Keating DJ, Vilsbøll T, Knop FK. Bahne E, et al. Among authors: hansen js, hansen m. JCI Insight. 2018 Dec 6;3(23):e93936. doi: 10.1172/jci.insight.93936. JCI Insight. 2018. PMID: 30518693 Free PMC article. Clinical Trial.

2

Small-bowel hemangiosarcoma and capsule endoscopy.

Knop FK, Hansen MB, Meisner S. Knop FK, et al. Among authors: hansen mb. Endoscopy. 2003 Jul;35(7):637. doi: 10.1055/s-2003-40224. Endoscopy. 2003. PMID: 12822111 No abstract available.

3

Increased levels of YKL-40 and interleukin 6 in patients with chronic pancreatitis and secondary diabetes.

Hansen M, Nielsen AR, Vilsbøll T, Lund A, Krarup T, Knop FK, Vestergaard H. Hansen M, et al. Pancreas. 2012 Nov;41(8):1316-8. doi: 10.1097/MPA.0b013e31824d9b93. Pancreas. 2012. PMID: 22647735

4

Effect of bile acid sequestrants on glycaemic control: protocol for a systematic review with meta-analysis of randomised controlled trials.

Hansen M, Sonne DP, Mikkelsen KH, Gluud LL, Vilsbøll T, Knop FK. Hansen M, et al. BMJ Open. 2012 Nov 12;2(6):e001803. doi: 10.1136/bmjopen-2012-001803. Print 2012. BMJ Open. 2012. PMID: 23148345 Free PMC article.

5

Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.

Hansen M, Sonne DP, Knop FK. Hansen M, et al. Curr Diab Rep. 2014;14(5):482. doi: 10.1007/s11892-014-0482-4. Curr Diab Rep. 2014. PMID: 24623198 Review.

6

Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion.

Sonne DP, Hansen M, Knop FK. Sonne DP, et al. Among authors: hansen m. Eur J Endocrinol. 2014 Aug;171(2):R47-65. doi: 10.1530/EJE-14-0154. Epub 2014 Apr 23. Eur J Endocrinol. 2014. PMID: 24760535 Review.

7

Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses.

Rohde U, Sonne DP, Christensen M, Hansen M, Brønden A, Toräng S, Rehfeld JF, Holst JJ, Vilsbøll T, Knop FK. Rohde U, et al. Among authors: hansen m. J Clin Endocrinol Metab. 2016 May;101(5):2076-83. doi: 10.1210/jc.2016-1133. Epub 2016 Mar 22. J Clin Endocrinol Metab. 2016. PMID: 27003305 Clinical Trial.

8

Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.

Bahne E, Hansen M, Brønden A, Sonne DP, Vilsbøll T, Knop FK. Bahne E, et al. Among authors: hansen m. Diabetes Obes Metab. 2016 Oct;18(10):955-61. doi: 10.1111/dom.12697. Epub 2016 Jul 13. Diabetes Obes Metab. 2016. PMID: 27265206 Review.

9

Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials.

Hansen M, Sonne DP, Mikkelsen KH, Gluud LL, Vilsbøll T, Knop FK. Hansen M, et al. J Diabetes Complications. 2017 May;31(5):918-927. doi: 10.1016/j.jdiacomp.2017.01.011. Epub 2017 Jan 24. J Diabetes Complications. 2017. PMID: 28238556 Review.

10

Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamer.

Brønden A, Mikkelsen K, Sonne DP, Hansen M, Våben C, Gabe MN, Rosenkilde M, Tremaroli V, Wu H, Bäckhed F, Rehfeld JF, Holst JJ, Vilsbøll T, Knop FK. Brønden A, et al. Among authors: hansen m. Diabetes Obes Metab. 2018 Jul;20(7):1623-1631. doi: 10.1111/dom.13272. Epub 2018 Mar 26. Diabetes Obes Metab. 2018. PMID: 29493868 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,175 results

Search Page

Filters